RxDoctor Payments Data

Ali Hazama, MD

Neurological Surgery · Syracuse, NYNPI 1386080158

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (37.5%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Spineology Inc. accounts for 85.9% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2023 at $31,992 and has fallen 52.6% since, to $15,159 in 2025.

$83,019in general payments, 2019–2025

Across 130 payments — averaging $638.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spineology Inc.$71K
  • Seaspine Orthopedics Corporation$3K
  • Medical Device Business Services, Inc.$3K
  • Synergy Biomedical, LLC$2K
  • Johnson & Johnson$1K
  • Medtronic$706
  • plus $2K from 16 others

What the payments were for

  • Consulting fees$27,11833%
  • Speaking & faculty fees$16,50020%
  • Travel & lodging$31,16138%
  • Food & beverage$8,24110%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$83,019 in reported general payments places this provider in the 85th percentile of 446 neurological surgery providers in New York.

See all neurological surgery providers in New York →

Medicare billing

Part B allowed, 2024
$139,449
Medicare patients
173
Services billed
410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin14$110

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Syracuse

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →